Concepedia

Rika Nakahashi-Ouchida

RN

Statistics

Publications

7

Citations

199

H-Index

7

Active since

2021

Affiliations

The University of Tokyo(Current)

University of California San Diego

Chiba University

University of Alabama at Birmingham

Kyoto University

Rika Nakahashi-Ouchida is an author at The University of Tokyo specializing in immunology, medicine, and precision vaccinology.

ORCID

Top concepts

Publications per year

2021–2023

7

Publications

7

Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial

Yoshikazu Yuki, Masanori Nojima, Osamu Hosono et al. · The Lancet Microbe · 2021 · 50 citations · Full text

A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci

Rika Nakahashi-Ouchida, Yohei Uchida, Yoshikazu Yuki et al. · Vaccine · 2021 · 45 citations · Full text

, , +18

Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System

Yoshikazu Yuki, Yohei Uchida, Shin‐ichi Sawada et al. · Molecular Pharmaceutics · 2021 · 35 citations · Full text

Development of Antibody-Fragment–Producing Rice for Neutralization of Human Norovirus

Ai Sasou, Yoshikazu Yuki, Shiho Kurokawa et al. · Frontiers in Plant Science · 2021 · 21 citations · Full text

, , +13

Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults

Yoshikazu Yuki, Masanori Nojima, Koji Kashima et al. · Vaccine · 2022 · 19 citations · Full text

, , +16

1–5 of 7